liquid biopsy

In liquid biopsy race, Freenome lands $65 million, led by Andreessen Horowitz

Freenome, a two-year-old liquid biopsy diagnosis platform that detects the cell-free DNA sequencing of cancer, has raised a huge Series A round — $65 millionĀ — led by Andreessen Horowitz,